Aditxt, Inc. (ADTX): Entry into a Material Definitive Agreement
Aditxt, Inc. (ADTX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ea029834801ex10-1.htm FORM OF AMENDMENT NO. 2 TO NOTE PURCHASE AGREEMENT Exhibit 10.1 AMENDMENT NO. 2 TO NOTE PURCHASE AGREEMENT THIS AMENDMENT NO. 2 TO NOTE PURCHASE AGREEMENT (this “ Amendment No. 2 ”) is dated as of July [__], 2026, by and among Aditxt, Inc., a Delaw
How this was made
The 30-second read
Why it matters
For traders, the actionable element is the incremental financing structure: a new investor becomes a buyer, and additional notes are issued to an existing buyer (Cavalry SPV) and a new party (Doug Mergenthaler). This can shift perceived liquidity and credit risk, especially for small-cap issuers.
Market read
This is a fresh SEC filing that updates Aditxt’s capital structure through additional secured notes and buyer changes, which can influence near-term valuation and credit-risk pricing.
What to watch
Key deal terms are missing from the excerpt (purchase price, principal amounts, interest rate, maturity, security/covenant changes). Those details likely determine whether the market treats this as refinancing versus fresh leverage.
Background
The 8-K reports entry into a material definitive agreement via Amendment No. 2 to a June 3, 2026 note purchase agreement, including a new buyer joinder and issuance of additional notes.
Ticker impact
Aditxt entered Amendment No. 2 to its note purchase agreement, adding a new buyer and issuing additional notes to Cavalry SPV and Doug Mergenthaler.
Likely modest, with direction dependent on whether the market views the additional notes as supportive liquidity versus dilution of balance-sheet flexibility.
The 8-K is a primary-source financing amendment, but the excerpt does not provide principal size, pricing, maturity, or covenants, limiting precision on magnitude and credit impact.
Market effects
Signals ongoing capital-structure management typical for pre-profit biotech/healthtech issuers, potentially read across to similarly leveraged small caps.
No clear regional spillover beyond US small-cap credit sentiment.
Limited, as the disclosure is company-specific and not tied to global macro or cross-border financing.
Counterpoint
If the additional notes replace or restructure earlier obligations (original note cancellation is mentioned), the net effect could be neutral or even credit-positive despite being “additional” issuance.
Key entities
- issuerAditxt, Inc.
Subject of the 8-K; borrower under the note purchase agreement and party to Amendment No. 2.
- issuer_subsidiaryIgnite Proteomics LLC
Co-borrower under the note purchase agreement referenced in the amendment.
- lender_investorCavalry Fund I SPV I LP
Existing buyer that receives a Cavalry SPV Additional Note; original note is surrendered/cancelled.
- new_investorDoug Mergenthaler
New buyer under the note purchase agreement receiving a Mergenthaler Additional Note.
